A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

Nature Genetics

Volumn 39, Issue 7, 2007, Pages 870-874

  Hunter, David J ^a,c   Kraft, Peter ^b   Jacobs, Kevin B ^d   Cox, David G ^a,b   Yeager, Meredith ^c,e   Hankinson, Susan E ^a   Wacholder, Sholom ^c   Wang, Zhaoming ^c,e   Welch, Robert ^c,e   Hutchinson, Amy ^c,e   Wang, Junwen ^c,e   Yu, Kai ^c   Chatterjee, Nilanjan ^c   Orr, Nick ^c   Willett, Walter C ^a,b   Colditz, Graham A ^f   Ziegler, Regina G ^c   Berg, Christine D ^c   Buys, Saundra S ^g   McCarty, Catherine A ^h   Feigelson, Heather Spencer ⁱ   Calle, Eugenia E ⁱ   Thun, Michael J ⁱ   Hayes, Richard B ^c   Tucker, Margaret ^c   Gerhard, Daniela S ^c   Fraumeni, Joseph F ^c   Hoover, Robert N ^c   Thomas, Gilles ^c   Chanock, Stephen J ^c   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Bioinformed Consulting Services   (United States)

^e SAIC FREDERICK INC   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h MARSHFIELD CLINIC   (United States)

ⁱ AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; PROTEIN TYROSINE KINASE;

ALLELE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE LOCUS; GENOME; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; ALLELES; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RISK FACTORS;

EID: 34250001297     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng2075     Document Type: Article

References (23)

1. Pharoah, P.D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33-36 (2002).
2. Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117-1130 (2003).
3. Risch, H.A. et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J. Natl. Cancer Inst. 98, 1694-1706 (2006).
4. Hirschhorn, J.N. & Daly, M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108 (2005).
5. Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
6. Easton, D.F. et al. A genome-wide association study identifies multiple breast cancer susceptibility loci. Nature, advance online publication 27 May 2007 (doi:10.1038/nature05887).
7. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649 (2007).
8. Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631-637 (2007).
9. Tworoger, S.S., Eliassen, A.H., Sluss, P. & Hankinson, S.E. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J. Clin. Oncol. 25, 1482-1488 (2007).
10. Grose, R. & Dickson, C. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 16, 179-186 (2005).
11. Minichiello, M.J. & Durbin, R. Mapping trait loci by use of inferred ancestral recombination graphs. Am. J. Hum. Genet. 79, 910-922 (2006).
12. Eliassen, A.H., Tworoger, S.S., Mantzoros, C.S., Pollak, M.N. & Hankinson, S.E. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol. Biomarkers Prev. 16, 161-164 (2007).
13. Hayes, R.B. et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control. Clin. Trials 21, 349S-355S (2000).
14. Stevens, V.L., Rodriguez, C., Pavluck, A.L., Thun, M.J. & Calle, E.E. Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 15, 1226-1228 (2006).
15. Bruzzi, P., Green, S.B., Byar, D.P., Brinton, L.A. & Schairer, C. Estimating the population attributable risk for multiple risk factors using case-control data. Am. J. Epidemiol. 122, 904-914 (1985).
16. Moffa, A.B. & Ethier, S.P. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. J. Cell. Physiol. 210, 720-731 (2007).
17. Chanock, S.J. et al. What constitutes replication of a genotype-phenotype association? Summary of an NCI-NHGRI working group. Nature (in the press).
18. Wang, H., Thomas, D.C., Pe'er, I. & Stram, D.O. Optimal two-stage genotyping designs for genome-wide association scans. Genet. Epidemiol. 30, 356-368 (2006).
19. Falush, D., Stephens, M. & Pritchard, J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587 (2003).
20. Kraft, P., Cox, D.G., Paynter, R.A., Hunter, D. & De Vivo, I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet. Epidemiol. 28, 261-272 (2005).
21. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
22. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
23. Patterson, N., Price, A.L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).